Development of Nivolumab/Ipilimumab-Associated Autoimmune Nephritis during Steroid Therapy

Immunotherapy using immune checkpoint inhibitors revolutionized therapies for a variety of malignancies. Nivolumab, an antibody blocking programmed cell death 1 protein, and ipilimumab that blocks cytotoxic T-lymphocyte-associated protein 4 effectively target tumor cells by disinhibiting the endogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebauer, Ellen, Bechtel-Walz, Wibke, Schell, Christoph, Erbel, Michelle, Walz, Gerd, Hermle, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460889/
https://www.ncbi.nlm.nih.gov/pubmed/34703826
http://dx.doi.org/10.1159/000517502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460889/
https://www.ncbi.nlm.nih.gov/pubmed/34703826
http://dx.doi.org/10.1159/000517502

Ejemplares similares